TY - JOUR
T1 - Letter to the Editor
T2 - Letter to the Editor regarding ‘Early impacts of the “National Suicide Prevention Trial” on trends in suicide and hospital admissions for self-harm in Australia’
AU - Bastiampillai, Tarun
AU - Wu, Aaron
AU - Giam, Andrew
AU - Tibrewal, Prashant
PY - 2024/1
Y1 - 2024/1
N2 - Australia’s suicide rates have been largely unchanged for decades, despite multiple suicide prevention strategies, several national mental health plans, new mood disorder–specific national organisations (e.g. Beyond Blue) and rising antidepressant use (Jorm, 2019). The National Suicide Prevention Trial (NSPT) (2016–2021) was the latest such trial, funded by the Australian Government (Page et al., 2023). Conducted over 12 regional sites across Australia, its aim was to develop individualised suicide prevention strategies targeting specific at-risk demographic groups.
AB - Australia’s suicide rates have been largely unchanged for decades, despite multiple suicide prevention strategies, several national mental health plans, new mood disorder–specific national organisations (e.g. Beyond Blue) and rising antidepressant use (Jorm, 2019). The National Suicide Prevention Trial (NSPT) (2016–2021) was the latest such trial, funded by the Australian Government (Page et al., 2023). Conducted over 12 regional sites across Australia, its aim was to develop individualised suicide prevention strategies targeting specific at-risk demographic groups.
KW - Suicide
KW - Hospital Admissions
KW - Self-Harm
KW - Australia
UR - http://www.scopus.com/inward/record.url?scp=85173766572&partnerID=8YFLogxK
U2 - 10.1177/00048674231201081
DO - 10.1177/00048674231201081
M3 - Letter
AN - SCOPUS:85173766572
SN - 0004-8674
VL - 58
SP - 94
EP - 96
JO - Australian and New Zealand Journal of Psychiatry
JF - Australian and New Zealand Journal of Psychiatry
IS - 1
ER -
